The α2‐AR agonist guanfacine is an anti‐anxiety and depression drug, and it is reported that the key to guanfacine in the treatment of anxiety and depression lies in activating α2‐AR in the amygdala. The gene discussed is ADORA2A; the disease is depressive disorder.